Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Illumina, Inc.
Illumina Inc engages in life science tools and machines for analyzing genetic material. The company primarily engages in microarray and genome sequencing machines and disposables. It also provides sequencing services through its products.
IPO Date: July 28, 2000
Sector: Healthcare
Industry: Life Sciences Tools and Services
Market Cap: $15.38B
Activated in VL: True
Average Daily Range
Avg Daily Range: $2.14 | 1.71%
Avg Daily Range (30 D): $1.40 | 1.49%
Avg Daily Range (90 D): $1.52 | 1.84%
Institutional Daily Volume
Avg Daily Volume: 1.24M
Avg Daily Volume (30 D): 1.92M
Avg Daily Volume (90 D): 1.86M
Trade Size
Avg Trade Size (Sh.): 87
Avg Trade Size (Sh.) (30 D): 50
Avg Trade Size (Sh.) (90 D): 52
Institutional Trades
Total Inst.Trades: 24,240
Avg Inst. Trade: $6.87M
Avg Inst. Trade (30 D): $9.93M
Avg Inst. Trade (90 D): $7.12M
Avg Inst. Trade Volume: .06M
Avg Inst. Trades (Per Day): 5
Market Closing Trades
Avg Closing Trade: $20.23M
Avg Closing Trade (30 D): $37.28M
Avg Closing Trade (90 D): $28.25M
Avg Closing Volume: 112.16K
   
News
Jul 21, 2025 @ 11:00 AM
Standard BioTools Schedules Second Quarter Earning...
Source: Marissa Bychir
Jun 21, 2025 @ 12:00 PM
Long Read Sequencing Market Projected to Reach USD...
Source: Sns Insider
Jun 16, 2025 @ 8:00 PM
Saudia Arabia Introduces Strategic Healthcare Visi...
Source: Riyadh, Kingdom Of Saudi Arabia
Jun 12, 2025 @ 8:58 AM
Molecular Diagnostics for Cancer Market Research 2...
Source: Researchandmarkets.Com
Jun 6, 2025 @ 9:36 AM
Companion Diagnostic Markets Report 2025-2029: Dia...
Source: Researchandmarkets.Com
Financials
  TTM Q1 2025 Q4 2024
Basic EPS $-6.05 $.83 $1.17
Diluted EPS $-6.07 $.82 $1.17
Revenue $ 4.34B $ 1.04B $ 1.1B
Gross Profit $ 2.88B $ 683M $ 728M
Net Income / Loss $ -966M $ 131M $ 187M
Operating Income / Loss $ -557M $ 164M $ 175M
Cost of Revenue $ 1.46B $ 358M $ 376M
Net Cash Flow $ 5M $ -14M $ 258M
PE Ratio    
Splits
Sep 23, 2008:   2:1